The WACC of Biostem Technologies Inc (BSEM) is 6.5%.
Range | Selected | |
Cost of equity | 5.7% - 7.4% | 6.55% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 4.5% - 4.5% | 4.5% |
WACC | 5.7% - 7.3% | 6.5% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.4 | 0.45 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.7% | 7.4% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.02 | 0.02 |
Cost of debt | 4.5% | 4.5% |
After-tax WACC | 5.7% | 7.3% |
Selected WACC | 6.5% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
BSEM | Biostem Technologies Inc | 0.02 | 2.45 | 2.42 |
AVCR.V | Avricore Health Inc | 1.01 | 1.59 | 0.92 |
CPMD | CannaPharmaRx Inc | 3.21 | -0.6 | -0.18 |
IPCI.TO | Intellipharmaceutics International Inc | 1.06 | -0.25 | -0.14 |
KAYS | Kaya Holdings Inc | 5.13 | 0.94 | 0.2 |
KOAN | Resonate Blends Inc | 27.07 | 0.88 | 0.04 |
MJ.CN | True Leaf Brands Inc | 8.68 | 1.01 | 0.14 |
MLCL.CN | Molecule Holdings Inc | 10.9 | 1.39 | 0.15 |
MMJ.CN | Matica Enterprises Inc | 0.17 | 1.15 | 1.02 |
SPR.CN | Sproutly Canada Inc | 1.34 | 0.44 | 0.22 |
Low | High | |
Unlevered beta | 0.15 | 0.21 |
Relevered beta | 0.1 | 0.18 |
Adjusted relevered beta | 0.4 | 0.45 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BSEM:
cost_of_equity (6.55%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.4) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.